Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Inogen stock | $61.81

Learn how to easily invest in Inogen stock.

Inogen, Inc
NASDAQ: INGN - USD
MEDICAL DEVICES
$78.68
-$1.09 (-1.37%)

Inogen, Inc is a medical devices business based in the US. Inogen shares (INGN) are listed on the NASDAQ and all prices are listed in US Dollars. Inogen employs 938 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Inogen

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – INGN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Inogen stock price (NASDAQ: INGN)

Use our graph to track the performance of INGN stocks over time.

Inogen shares at a glance

Information last updated 2021-07-30.
Latest market close$61.81
52-week range$26.57 - $79.71
50-day moving average $67.78
200-day moving average $58.80
Wall St. target price$69.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $0.29

Buy Inogen shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Inogen stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Inogen price performance over time

Historical closes compared with the close of $61.81 from 2021-05-28

1 week (2021-07-23) N/A
1 month (2021-07-02) -3.63%
3 months (2021-05-03) -9.40%
6 months (2021-01-30) N/A
1 year (2020-07-30) N/A
2 years (2019-07-30) N/A
3 years (2018-07-30) N/A
5 years (2016-07-30) N/A

Is Inogen under- or over-valued?

Valuing Inogen stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Inogen's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Inogen's PEG ratio

Inogen's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.48. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Inogen's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Inogen's EBITDA

Inogen's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $8.5 million.

The EBITDA is a measure of a Inogen's overall financial performance and is widely used to measure a its profitability.

Inogen financials

Revenue TTM $306.9 million
Gross profit TTM $138.2 million
Return on assets TTM -1.44%
Return on equity TTM -1.41%
Profit margin -1.62%
Book value $15.92
Market capitalisation $1.8 billion

TTM: trailing 12 months

Shorting Inogen shares

There are currently 379,008 Inogen shares held short by investors – that's known as Inogen's "short interest". This figure is 3.5% down from 392,692 last month.

There are a few different ways that this level of interest in shorting Inogen shares can be evaluated.

Inogen's "short interest ratio" (SIR)

Inogen's "short interest ratio" (SIR) is the quantity of Inogen shares currently shorted divided by the average quantity of Inogen shares traded daily (recently around 131600). Inogen's SIR currently stands at 2.88. In other words for every 100,000 Inogen shares traded daily on the market, roughly 2880 shares are currently held short.

However Inogen's short interest can also be evaluated against the total number of Inogen shares, or, against the total number of tradable Inogen shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Inogen's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Inogen shares in existence, roughly 20 shares are currently held short) or 0.0189% of the tradable shares (for every 100,000 tradable Inogen shares, roughly 19 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Inogen.

Find out more about how you can short Inogen stock.

Inogen share dividends

We're not expecting Inogen to pay a dividend over the next 12 months.

Inogen share price volatility

Over the last 12 months, Inogen's shares have ranged in value from as little as $26.57 up to $79.71. A popular way to gauge a stock's volatility is its "beta".

INGN.US volatility(beta: 0.92)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Inogen's is 0.9222. This would suggest that Inogen's shares are less volatile than average (for this exchange).

Inogen overview

Inogen, Inc. , a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Frequently asked questions

What percentage of Inogen is owned by insiders or institutions?
Currently 1.486% of Inogen shares are held by insiders and 96.744% by institutions.
How many people work for Inogen?
Latest data suggests 938 work at Inogen.
When does the fiscal year end for Inogen?
Inogen's fiscal year ends in December.
Where is Inogen based?
Inogen's address is: 326 Bollay Drive, Goleta, CA, United States, 93117
What is Inogen's ISIN number?
Inogen's international securities identification number is: US45780L1044
What is Inogen's CUSIP number?
Inogen's Committee on Uniform Securities Identification Procedures number is: 45780L104

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site